Clinical Trial Update: Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating decitabine in melanoma and other advanced cancers has completed. The study explored safety and dosing across hematologic and solid tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Melanoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine)

Snippet

Sponsor: California Cancer Consortium | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Status: COMPLETED